Challenging the conventional wisdom of field medical strategy
Field Medical teams often rely on relationship length, contact frequency, and number of interactions as indicators of strong engagement. But do these drivers...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s global experts in life sciences support clinical development and medical affairs teams to optimize their role as the key interface between health technology manufacturers and the scientific and medical community. Our focus is helping our medical affairs clients unlock the clinical potential of new technologies for the benefit of patients, providers, payers, and the broader healthcare system. Our projects encompass vision and strategy setting, medical and clinical planning, customer insights, evidence generation, publication and communications, launch readiness, and field excellence.
Contact CRA’s medical affairs experts to explore what CRA can tailor to your needs.
Field Medical teams often rely on relationship length, contact frequency, and number of interactions as indicators of strong engagement. But do these drivers...
Insights from the MAPS New Orleans 2025 roundtable session. The session highlighted the essential talent needs—such as competencies, qualifications, and...